Navigation Links
Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
Date:1/16/2008

SOUTH SAN FRANCISCO, Calif., Jan. 16 /PRNewswire/ -- Cerimon Pharmaceuticals, Inc., announced today it has initiated two randomized, double-blind, placebo-controlled Phase II/III clinical studies of its once- daily topical diclofenac sodium patch to treat mild to moderate pain. One of the studies, designated the "SUPPORT" (Stop Underlying Pain with a diclofenac Patch and Obtain Relief Topically) study, will assess the efficacy and safety of Cerimon's patch compared to placebo for the treatment of pain due to acute mild to moderate ankle sprains. The second study, designated the "ACTIVE" (A Clinical Trial to Investigate the effectiVEness of diclofenac pain patch) study, will assess the safety and efficacy of Cerimon's patch compared to placebo for the treatment of pain due to mild to moderate tendonitis or bursitis of the shoulder, elbow, or wrist. Each study will enroll over 300 subjects, with 50 percent of the subjects randomized to receive the diclofenac sodium patch and the other half to receive placebo.

Paul J. Sekhri, President and CEO of Cerimon Pharmaceuticals, stated, "Our diclofenac patch is designed to offer convenient, site-specific pain relief to patients with mild to moderate forms of musculoskeletal pain without systemic side effects associated with currently available oral NSAIDs. Consumers in Japan and several other countries have responded strongly to the advantages of topical diclofenac patches virtually identical to our patch, and we believe this provides an indication of the potential market demand in the U.S. Cerimon is moving its program forward aggressively to address this unmet medical need, allowing us to build a leadership position in the US pain market."

This is the second late-stage development program Cerimon commenced in the past year. In April 2007, the Company initiated a Phase IIb study of Simulect(R) (basiliximab) for moderate-to-severe steroid-refractory ulcerative colitis.

Pain Market

Musculoskel
'/>"/>

SOURCE Cerimon Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
2. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
3. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
6. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
7. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
8. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
9. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
10. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
11. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... WEST JORDAN, Utah , Aug. 3, 2015  BC ... Solutions has acquired Ohio Valley Medical Systems, one of ... MRI systems.  The addition of Ohio Valley Medical Systems ... to now include Hitachi MRI.   "We ... Mark Alvarez , President and CEO of BC Technical. ...
(Date:8/3/2015)... MINNEAPOLIS , Aug. 3, 2015 ... become a significant shareholder and will become the ... Solutions for cardiology-related diagnostic and monitoring offerings. ... milestone for Preventice Solutions," said Jon Otterstatter ... CEO, Preventice Solutions.  "We are thrilled to partner ...
(Date:8/3/2015)... ROSEMONT, Ill. , Aug. 3, 2015 ... ankle problem, and you,re looking for the best possible ... for the best outcome too, and now there,s a ... there. Following steps recommended by the American Orthopaedic ... after surgery can help you avoid complications and heal ...
Breaking Medicine Technology:BC Technical Acquires Ohio Valley Medical Systems 2Boston Scientific Announces Equity Investment And Sales Cooperation Agreement With Preventice Solutions 2Patient Guide: How to Prepare for Surgery 2
... Eli Lilly and Company,(NYSE: LLY ) has ... Quality Assurance (NCQA) for its Tools that Empower(TM),Depression ... Care Management Program is designed,for managed care organizations ... care around Major Depressive Disorder (MDD). Lilly created ...
... compared with cold dissection ... ... surgical device company, today announced that a study published in,the Annals ... Tissue Welding Technology in total tonsillectomy,patients resulted in significantly less intraoperative ...
Cached Medicine Technology:Lilly Receives NCQA Design Certification for Depression Care Management Program 2Lilly Receives NCQA Design Certification for Depression Care Management Program 3Study Finds Starion Instruments' Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients 2
(Date:8/4/2015)... ... August 04, 2015 , ... It’s been called “cosmetics heaven,” “mecca for make-up,” ... Naimie’s Beauty Center in LA. Now MENAJI is part of that experience acting as ... Beauty Center has been a favorite of makeup artists and hair pros as well ...
(Date:8/4/2015)... ... August 04, 2015 , ... A new ... America IT reseller channel will grow at least 6 percent in 2015, as ... pace and greater than their OEM/vendor partners. , The 2112 Group’s 2015 ...
(Date:8/4/2015)... Tel Aviv, Israel (PRWEB) , ... August 04, ... ... company, today announced the launch of a new product suite designed to provide ... tracks signals and trends based on multi-sourced and cross-referenced data from regulatory filings ...
(Date:8/4/2015)... NY (PRWEB) , ... August 04, 2015 , ... ... mortgage lender specializing in healthcare finance, announced the closing of a $118 million ... two campus health system located in Smithfield and Clayton, North Carolina. JHSC ...
(Date:8/4/2015)... ... August 04, 2015 , ... Updated enrollment data on ... research team, can now be accessed at http://www.AISHealth.com . The data is free ... Health Plans: 2015, the tables and charts on the website’s “Data” section include:, ...
Breaking Medicine News(10 mins):Health News:MENAJI Shines in Make-Up Mecca for Stars 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2
... , ... in online-based medical transcription, has tapped Randy Olver as its new CEO, effective immediately. ... (Vocus) November 5, 2009 -- ... its new CEO, effective immediately., , , , ,Emdat’s founding partners, who remain actively involved ...
... VOLC ), a leader in the development, manufacture and ... and peripheral artery disease, today reported revenues of $53.9 million ... for the quarter ended September 30, 2009, represent an increase ... third quarter of 2008. Revenues for the third quarter of ...
... 5 STINSON Brand Innovation is offering a custom e-book, "Notes on ... 8-14. , The e-book is one in a series of e-books titled ... on C la s ... no charge at http://www.stinsonbrandinnovation.com/ebooks/SBI_NotesOnNursing.htm , "This is a way we ...
... human genomes could be sequenced next year, company says , ... says it has developed a lower-cost DNA platforming sequence. ... full human genomes, was published Nov. 5 in Science ... cost for three genomic DNA nanoarrays ranged from $1,726 to ...
... A drug already approved for the treatment of lymphoma may ... in children and teens, according to an early-stage study published ... The study drug, Bortezomib, was found to be effective against ... While key experiments were in animals, the cancer studied closely ...
... -- Picture it: One jerk in a bar spends the ... of the evening, the women aren,t receptive to even the ... in evolutionary theory. Males increase their fitness by acquiring more ... and therein lies the conflict. Researchers at Binghamton ...
Cached Medicine News:Health News:Randy Olver Named Emdat CEO, Will Lead Next Phase of Growth for Medical Transcription Solutions Provider 2Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 2Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 3Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 4Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 5Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 6Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 7Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 8Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 9Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 10Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 11Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 12Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 13Health News:Volcano Reports 22 Percent Increase in Third Quarter Revenues 14Health News:National Nurse Practitioner Week Recognized by STINSON Brand Innovation With Offer of 'Notes on Nursing' e-book 2Health News:Approved lymphoma drug shows promise in early tests against bone cancer 2Health News:Mom was right: Nice guys don't always finish last 2
... is specifically designed to work with the ... is a small tank blotter that incorporates ... (low buffer requirements and fast transfer rates), ... semi-dry blotting such as arcing and buffer ...
... Blot Module allows you to easily transfer proteins ... fits neatly into the XCell SureLock and XCell ... assembly. It requires less than 200 ml of ... Tough platinized titanium and stainless steel electrodes create ...
... The GENIE is the proven electrophoretic ... the ultimate in field uniformity. Its design ... the electrodes which, when coupled with a ... battery charger, creates a high field in ...
Semi-Dry Blotting Unit for 10 x 10cm Gels...
Medicine Products: